Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials

Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials

Hannu Uusitalo,1 Evgeniy Egorov,2 Kai Kaarniranta,3 Yuri Astakhov,4 Auli Ropo5 On behalf of the Switch Study Tafluprost Study Groups 1Department of Ophthalmology, SILK, University of Tampere, Tampere University Hospital, Tampere, Finland; 2Department of Ophthalmology, The Russian National Research...

Full description

Saved in:
Bibliographic Details
Main Authors: Uusitalo H, Egorov E, Kaarniranta K, Astakhov Y, Ropo A
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
preservative-free tafluprost
Taflotan®
preserved latanoprost
Xalatan®
ocular surface disease
ocular symptoms and signs
IOP
patient-rated outcome
meta-analysis.
Ophthalmology
RE1-994
Online Access:https://doaj.org/article/318b9db2728f4009bca78d6c06d9b94c
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/318b9db2728f4009bca78d6c06d9b94c

Similar Items